SironRX Therapeutics
closedSironRX is developing novel therapies that promote dermal wound repair and reduce scarring.
Launch date
Employees
Market cap
-
Enterprise valuation
$14—20m (Dealroom.co estimates Aug 2011.)
Cleveland Ohio (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$500k | Seed | ||
$3.4m | Series A | ||
Total Funding | $3.9m |